PDCO
38
3
RIG
58
4
AMP
73
4
MAR
65
2
ABT
62
5
ITW
62
4
IVZ
48
2
HD
55
8
HRL
41
2
F
47
4
XYL
45
8
SYK
68
4
ES
31
3
ICE
62
3
IPG
53
4
NTRS
57
2
SYY
49
2
ILMN
37
5
BWA
46
2
GRMN
64
2
PDCO
38
3
RIG
58
4
AMP
73
4
MAR
65
2
ABT
62
5
ITW
62
4
IVZ
48
2
HD
55
8
HRL
41
2
F
47
4
XYL
45
8
SYK
68
4
ES
31
3
ICE
62
3
IPG
53
4
NTRS
57
2
SYY
49
2
ILMN
37
5
BWA
46
2
GRMN
64
2
Financhill
Back

Adaptimmune Therapeutics PLC Vs. Target Industry Stock Comparison

Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.65
Seasonality Move:
50.57%
Sell
20

TGT
Target

Last Price:
125.04
Seasonality Move:
4.08%
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $121.59. The Score for TGT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $121.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 36.24 Sell
Chaikin Money Flow: -608296 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.81 - 1.21) Sell

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.85 Sell
Relative Strength Index (14 RSI): 23.91 Sell
Chaikin Money Flow: -8404826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.56 - 157.62) Sell
Bollinger Bands (100): (142.35 - 156.95) Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.73 Sell
50-day SMA: 0.85 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.83 Sell
200-day EMA: 1 Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.51 Sell
20-day SMA: 148.61 Sell
50-day SMA: 151.64 Sell
200-day SMA: 153.85 Sell
8-day EMA: 141.24 Sell
20-day EMA: 147.16 Sell
50-day EMA: 149.8 Sell
200-day EMA: 149.63 Sell

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):